First Time Loading...

Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 69.67 USD 1.93% Market Closed
Updated: Apr 20, 2024
Section:
 

Relative Value

The Relative Value of one PBH stock under the Base Case scenario is 81.97 USD. Compared to the current market price of 69.67 USD, Prestige Consumer Healthcare Inc is Undervalued by 15%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PBH Relative Value
Base Case
81.97 USD
Undervaluation 15%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
3
vs Industry
38
Median 3Y
2.7
Median 5Y
2.5
Industry
2.3
Forward
3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
13.2
Median 5Y
12.1
Industry
22.2
Forward
15.9
More Details
14.4
P/OCF
P/OCF
Price to OCF
14.4
vs History
4
vs Industry
28
Median 3Y
12.3
Median 5Y
10.6
Industry
16.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
19
Median 3Y
14
Median 5Y
-12.2
Industry
22.6
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
7
vs Industry
37
Median 3Y
1.9
Median 5Y
1.8
Industry
2
More Details
4.1
EV/S
EV/S
Enterprise Value to Sales
4.1
vs History
26
vs Industry
29
Median 3Y
3.9
Median 5Y
3.8
Industry
2.5
Forward
4
More Details
7.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.3
vs History
15
vs Industry
28
Median 3Y
7
Median 5Y
6.6
Industry
5
More Details
460.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
460.7
vs History
7
vs Industry
0
Median 3Y
12.4
Median 5Y
11.6
Industry
13.2
Forward
11.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
32
Median 3Y
12.5
Median 5Y
12.2
Industry
16.5
Forward
13
More Details
19.1
EV/OCF
EV/OCF
Enterprise Value to OCF
19.1
vs History
15
vs Industry
24
Median 3Y
18
Median 5Y
17.5
Industry
15.5
More Details
19.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.8
vs History
20
vs Industry
20
Median 3Y
19.1
Median 5Y
18.5
Industry
17.2
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
3
vs Industry
47
Median 3Y
1.3
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

PBH Competitors Multiples
Prestige Consumer Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Prestige Consumer Healthcare Inc
NYSE:PBH
3.5B USD 3 -42.9 460.7 -221.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
689.5B USD 20.2 131.6 59.5 68.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.6 46.1 33.8 36.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
356B USD 4.4 8.8 11.7 15.5
US
Merck & Co Inc
NYSE:MRK
318.4B USD 5.3 872.4 43.5 84.9
UK
AstraZeneca PLC
LSE:AZN
169.7B GBP 4.6 35.4 139 223
CH
Roche Holding AG
SIX:ROG
176.3B CHF 3 15.3 8.5 10
CH
Novartis AG
SIX:NOVN
174.4B CHF 4.1 12.9 9.4 15.6
US
Pfizer Inc
NYSE:PFE
146.8B USD 2.5 69.3 10.6 15.8
P/E Multiple
Earnings Growth
US
Prestige Consumer Healthcare Inc
NYSE:PBH
Average P/E: 149
Negative Multiple: -42.9 		N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
131.6
346%
DK
Novo Nordisk A/S
CSE:NOVO B
46.1
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
8.8
-20%
US
Merck & Co Inc
NYSE:MRK
872.4
7 454%
UK
AstraZeneca PLC
LSE:AZN
35.4
168%
CH
Roche Holding AG
SIX:ROG
15.3
26%
CH
Novartis AG
SIX:NOVN
12.9
15%
US
Pfizer Inc
NYSE:PFE
69.3
680%

See Also

Summary
PBH intrinsic value, competitors valuation, and company profile.
DCF Valuation
PBH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PBH stock valuation using valuation multiples.
Wall Street Estimates
PBH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PBH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 129,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.